Terapia Tecar en Pacientes con Radiculopatía Lumbar: Un Ensayo Controlado Aleatorizado
Eficacia de la Terapia Tecar frente a la Fisioterapia Convencional y el Tratamiento Simulado en Pacientes con Radiculopatía Lumbar: Un Ensayo Controlado Aleatorizado
Lumbar radiculopathy is a common cause of low back and leg pain, most frequently resulting from lumbar disc herniation and nerve root irritation. Conservative management, including physical therapy modalities and exercise therapy, is generally recommended as first-line treatment for patients without progressive neurological deficits. Tecar therapy (Transfer of Energy Capacitive and Resistive) is a non-invasive electrotherapeutic modality that delivers high-frequency electromagnetic energy to deep tissues and has been proposed to reduce pain, enhance microcirculation, and promote tissue recovery. However, evidence regarding its effectiveness in lumbar radiculopathy remains limited.
The aim of this randomized controlled trial is to evaluate the efficacy of Tecar therapy in patients with lumbar radiculopathy and to compare its clinical effects with conventional physical therapy and sham Tecar treatment.
A total of 90 participants with unilateral L5 and/or S1 radiculopathy will be randomized into three groups: (1) conventional physical therapy, (2) Tecar therapy combined with standard physical therapy, and (3) sham Tecar therapy combined with standard physical therapy. All participants will receive standardized postural education and a home exercise program.
The primary outcome will be radicular leg pain intensity measured by the Visual Analog Scale (VAS) at Week 2. Secondary outcomes will include low back pain intensity (VAS), functional disability (Oswestry Disability Index), neuropathic pain characteristics (PainDETECT questionnaire), lumbar mobility (Modified-Modified Schober Test), nerve root irritability (Straight Leg Raise test), rescue analgesic consumption, and exercise adherence. Outcomes will be assessed at baseline, post-treatment (week 2), and follow-up visits at weeks 6 and 12.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
This assessor-blinded, randomized controlled trial will be conducted in the Department of Physical Medicine and Rehabilitation at İzmir City Hospital, a tertiary-level outpatient center. The study will be designed and reported according to CONSORT recommendations.
Participants aged 18-65 years with clinically diagnosed unilateral L5 and/or S1 radiculopathy and symptom duration between 6 weeks and 6 months will be eligible. Diagnosis will primarily be based on clinical findings consistent with radiculopathy, including dermatomal leg pain and supportive neurological examination findings, while lumbar MRI and/or EMG will be used as confirmatory evidence. After written informed consent is obtained, eligible participants will be randomly assigned in a 1:1:1 ratio to one of three groups using computer-generated randomization with concealed allocation.
Group 1 will receive conventional physical therapy consisting of hot pack, continuous ultrasound therapy, and transcutaneous electrical nerve stimulation (TENS). Group 2 will receive Tecar therapy in addition to standardized base therapy. Tecar treatment will include capacitive and resistive energy transfer applied to the lumbar paraspinal region and gluteal muscles. Group 3 will receive sham Tecar therapy using the same procedure as the active Tecar protocol but with zero energy output. All groups will additionally receive standardized postural education and a home exercise program.
Outcome assessments will be performed by an independent physiatrist blinded to group allocation at four time points: baseline, post-treatment (week 2), and follow-up visits at weeks 6 and 12. The primary outcome will be change in radicular leg pain intensity from baseline to Week 2, measured by the Visual Analog Scale (VAS). Secondary outcomes will include low back pain intensity (VAS), functional disability (Oswestry Disability Index), neuropathic pain features (PainDETECT questionnaire), lumbar mobility (Modified-Modified Schober Test), nerve root irritability assessed with the Straight Leg Raise test, rescue analgesic consumption, and exercise adherence.
The study aims to determine whether Tecar therapy provides additional clinical benefit over conventional physical therapy and to evaluate the effectiveness of Tecar therapy beyond placebo effects using a sham-controlled design.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Ertan Yilmaz, MD
- Número de teléfono: +905318431901
- Correo electrónico: ertnyilmzz@gmail.com
Ubicaciones de estudio
-
-
-
Izmir, Turquía (Türkiye), 35000
- Reclutamiento
- İzmir City Hospital
-
Contacto:
- Ertan Yilmaz, MD
- Número de teléfono: +905318431901
- Correo electrónico: ertnyilmzz@gmail.com
-
Izmir, Turquía (Türkiye)
- Reclutamiento
- İzmir Cİty Hospital
-
Contacto:
- Ertan Yilmaz, Medical Doctor, Specialist
- Número de teléfono: +905318431901
- Correo electrónico: ertnyilmzz@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Adults aged 18-65 years
- Clinical diagnosis of unilateral L5 and/or S1 lumbar radiculopathy
- Symptom duration between 6 weeks and 6 months
- Average radicular pain intensity ≥3 on the Visual Analog Scale (VAS) during the previous month
- Availability of lumbar MRI and/or EMG performed within the previous 6 months
- Willingness to participate and ability to provide written informed consent
Exclusion Criteria:
- Bilateral lumbar radiculopathy
- Lumbar spinal canal stenosis confirmed by imaging or suspected clinically (e.g., neurogenic claudication)
- Lower limb muscle strength <4/5 according to the Medical Research Council (MRC) scale
- Use of analgesic medications other than paracetamol during the study period
- Physical therapy treatment for low back or radicular pain within the past 3 months
- Contraindications to physical therapy modalities or Tecar therapy
- Any previous lumbar spine surgery, or interventional spinal procedures within the last 6 months
- Pregnancy, malignancy, or systemic neurological or rheumatologic disease
- Advanced spinal or lower extremity deformities (e.g., scoliosis >20°, grade 3-4 spondylolisthesis, vertebral fracture, advanced coxarthrosis)
- Inability to complete the intervention protocol or follow-up assessments
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Comparador activo: Conventional Physical Therapy
Participants in this group will receive conventional physical therapy consisting of hot pack, continuous ultrasound therapy, and transcutaneous electrical nerve stimulation (TENS) applied to the lumbar region. Treatments will be administered five times per week for two weeks (10 sessions). Participants will also receive standardized postural education and a home exercise program. |
Conventional physical therapy will include a combination of hot pack, continuous ultrasound therapy, and transcutaneous electrical nerve stimulation (TENS) applied to the lumbar region. Treatment sessions will be conducted five times per week for two weeks. Participants will also receive standardized postural education and a home exercise program. |
|
Experimental: Tecar Therapy
Participants in this group will receive Tecar therapy in addition to standardized base physical therapy consisting of hot pack and TENS. Tecar therapy will be applied to the lumbar paraspinal region and gluteal muscles using capacitive and resistive modes with adjustable energy output. Sessions will be performed three times per week for two weeks. Participants will also receive standardized postural education and a home exercise program. |
Tecar therapy (Transfer of Energy Capacitive and Resistive) will be applied using capacitive and resistive modes to the lumbar paraspinal region and gluteal muscles. Energy output will be adjusted to approximately 50-70% of the device capacity to achieve a comfortably warm sensation. Each session will last approximately 25 minutes and will be performed three times per week for two weeks. All applications will be delivered using a hypothermic electrode head. |
|
Comparador falso: Arm Title
Participants in this group will receive sham Tecar therapy in addition to standardized base physical therapy consisting of hot pack and TENS. The sham procedure will follow the same protocol as the active Tecar therapy, including identical electrode contact and treatment duration, but the device will be set to zero energy output, preventing any thermal or electrical effect. Participants will also receive standardized postural education and a home exercise program. |
Sham Tecar therapy will be delivered using the same device, electrode head, treatment duration, and therapist contact as the active Tecar therapy protocol. However, the device will be set to zero intensity output, preventing the delivery of electromagnetic energy or heat. This procedure is designed to mimic the active intervention while providing no therapeutic effect. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Radicular Leg Pain Intensity (Visual Analog Scale, VAS)
Periodo de tiempo: Baseline to Week 2
|
Change from baseline to Week 2 in average radicular leg pain over the previous 7 days, measured on a 10-cm VAS (0 = no pain, 10 = worst imaginable pain). |
Baseline to Week 2
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Low Back Pain Intensity (VAS)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12
|
Average low back pain over the previous 7 days, measured on a 10-cm VAS. |
Baseline, Week 2, Week 6, and Week 12
|
|
Radicular Leg Pain Intensity (VAS) at Follow-up
Periodo de tiempo: Baseline, Week 6, and Week 12
|
Average radicular leg pain over the previous 7 days, measured on a 10-cm VAS. |
Baseline, Week 6, and Week 12
|
|
Neuropathic Pain Characteristics (PainDETECT Questionnaire)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12
|
Neuropathic pain features will be assessed using the PainDETECT Questionnaire, a validated self-report instrument ranging from -1 to 38 points. Higher scores indicate a greater likelihood of neuropathic pain components. |
Baseline, Week 2, Week 6, and Week 12
|
|
Functional Disability (Oswestry Disability Index)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12
|
ODI version 2.0, percentage score from 0 to 100; higher scores indicate greater disability. |
Baseline, Week 2, Week 6, and Week 12
|
|
Lumbar Mobility (Modified-Modified Schober Test)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12
|
Lumbar spine mobility will be assessed using the Modified-Modified Schober Test. The distance between two skin marks placed over the lumbar spine will be measured during maximal forward flexion. |
Baseline, Week 2, Week 6, and Week 12
|
|
Nerve Root Irritability (Straight Leg Raise Test)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12
|
The Straight Leg Raise (SLR) test will be used to assess nerve root irritability. The angle at which radicular pain is reproduced during passive leg elevation will be measured using a goniometer. |
Baseline, Week 2, Week 6, and Week 12
|
|
Rescue Medication Consumption
Periodo de tiempo: Weeks 1, 2, 6, and 12
|
Total paracetamol intake (mg/week). |
Weeks 1, 2, 6, and 12
|
|
Exercise Adherence
Periodo de tiempo: Weeks 1, 2, 6, and 12
|
Self-reported percentage of target home exercise sessions completed. |
Weeks 1, 2, 6, and 12
|
Otras medidas de resultado
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Treatment Credibility and Expectancy
Periodo de tiempo: Baseline
|
Credibility/Expectancy Questionnaire, administered before the first treatment session. |
Baseline
|
|
Perceived Treatment Allocation
Periodo de tiempo: Week 2
|
Participant belief about the treatment received (active, control, or do not know), TECAR and sham groups only. |
Week 2
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Ertan Yilmaz, MD, Izmir City Hospital
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- 2024-KAEK-23
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Individual participant data will not be publicly shared due to institutional data protection policies and privacy regulations. Only aggregated data will be reported in scientific publications.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .